Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine

OBJECTIVE: This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient‐reported outcomes of health‐related quality of life (HRQoL) and disability categories. BACKGROUND: Migraine causes considerable disease‐related disability and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Janet H., Kurth, Tobias, Starling, Amaal J., Ayer, David W., Wietecha, Linda A., Port, Martha D., Rettiganti, Mallikarjuna, Ruff, Dustin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756324/
https://www.ncbi.nlm.nih.gov/pubmed/33249580
http://dx.doi.org/10.1111/head.14013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756324/
https://www.ncbi.nlm.nih.gov/pubmed/33249580
http://dx.doi.org/10.1111/head.14013

Ejemplares similares